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a b s t r a c t
The maternal vasculature within the placenta in primates and rodents is unique because it is lined by fetal
cells of the trophoblast lineage and not by maternal endothelial cells. In addition to trophoblast cells that
invade the uterine spiral arteries that bring blood into the placenta, other trophoblast subtypes sit at different
levels of the vascular space. In mice, at least ﬁve distinct subtypes of trophoblast cells have been identiﬁed
which engage maternal endothelial cells on the arterial and venous frontiers of the placenta, but which also
form the channel-like spaces within it through a process analogous to formation of blood vessels
(vasculogenic mimicry). These cells are all large, post-mitotic trophoblast giant cells. In addition to assuming
endothelial cell-like characteristics (endothelial mimicry), they produce dozens of different hormones that are
thought to regulate local and systemic maternal adaptations to pregnancy. Recent work has identiﬁed distinct
molecular pathways in mice that regulate the morphogenesis of trophoblast cells on the arterial and venous
sides of the vascular circuit that may be analogous to speciﬁcation of arterial and venous endothelial cells.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The placenta is a unique vascularized organ that acts as the
exchange station for gases and nutrients between the maternal
and fetal circulations. It also produces hormones that impact
maternal and fetal physiology, and protects the fetus from the
maternal immune system (Cross et al., 1994; Rawn and Cross,
2008; Watson and Cross, 2005). Proper placental function is
therefore a crucial step in mammalian development and defects
in the placenta can result in fetal abnormalities, death or preg-
nancy related complications in the mother. Most of the defects
resulting in pregnancy complications in both humans and knock-
out mice are associated with the vasculature of placenta (Cross,
1996; Kaufmann et al., 2003; Rossant and Cross, 2001; Watson and
Cross, 2005). The placenta has two vascular systems – fetal and
maternal – coming in close proximity to facilitate nutrient and gas
exchange. In primates and rodents, the maternal vascular space is
unique in that, unlike other organs, placenta-derived trophoblast
cells and not endothelial cells line the maternal side of the
vasculature (Wooding and Flint, 1994). In mice, various subtypes
of large, post-mitotic but polyploid trophoblast cells, called tro-
phoblast giant cells (TGCs), lie at different positions within the
maternal vascular space (Simmons et al., 2007). In humans,
extravillous cytotrophoblast cells engage the arteries and veins.
While the cells that invade the arteries have been well character-
ized in the human placenta (Zhou et al., 2003b), the characteristics
of the trophoblast cells that lie at the venous outﬂow and
bordering the intervillous space have not.
Within the placenta literature, the term vasculogenic mimicry
has been used to describe the process of trophoblast cells invading
into endothelial cell-lined spiral arteries and beginning to express
several molecules that are characteristic of endothelial cells
(Kaufmann et al., 2003; Khankin et al., 2010). Vasculogenic
mimicry is a term adapted from tumor biology that means
formation of ﬂuid conducting channels without the participation
of endothelial cells (Maniotis et al., 1999). Though this process of
spiral artery invasion and displacement of endothelial cells puts
trophoblast cells in the place of endothelial cells, for clarity in this
review we deﬁne this process as vascular invasion and ‘endothelial
mimicry’ and use the term ‘vasculogenic mimicry’ speciﬁcally for
the process by which trophoblast cells within the placenta itself
form vascular spaces de novo. We discuss the development of the
maternal vasculature within the placenta of mice and humans,
mechanisms of endothelial and vasculogenic mimicry suggested
by recent studies in mice, and comparisons between trophoblast,
endothelial and tumor cells.
Three anatomical layers of human and murine placentas
The mammalian placenta is a composite organ composed of
both maternal and fetal tissue. Primate and rodent placentas are
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‘hemochorial’ in that while fetal blood is contained within
endothelial cell-lined vessels, maternal blood is in contact with
specialized subtypes of trophoblast cells (Wooding and Flint,
1994). Despite gross dissimilarities between murine and human
placentas, they share several structural, cellular and molecular
features which have been described extensively elsewhere
(Georgiades et al., 2002; Rossant and Cross, 2001; Watson and
Cross, 2005). The murine placenta is composed of three distinct
cellular layers: maternal decidua derived from uterine stromal
cells across which maternal blood comes to the implantation site
through spiral arteries; the junctional zone where maternal
vessels lead into and out of TGC-lined vascular spaces; the
labyrinth which is the highly branched, large surface area for
nutrient and gas exchange (Fig. 1). The human placenta has three
analogous layers: an outermost decidua layer with spiral arteries;
the basal plate in humans is analogous to the junctional zone; the
collection of placental villi in humans into cotyledons is analogous
to the labyrinth, though the villi are much less densely packed and
the intervillous space is more open compared with the labyr-
inthine arrangement in rodents (Fig. 1). These layers are well
designed to bring blood into and away from the implantation site,
and expedite maximum nutrient and gas exchange while main-
taining a barrier between the fetal and maternal circulations.
Development of the mouse placenta — from blastocyst to
placenta
The major developmental steps giving rise to the mouse
placenta are now very well understood both at a cellular and
molecular level (Rossant and Cross, 2001; Simmons and Cross,
2005; Watson and Cross, 2005). The epithelial part of the placenta
is composed of cell types of the trophoblast lineage, which
develops from the trophectoderm layer of blastocyst. Polar tro-
phectoderm cells overlying the inner cell mass follow a different
cell fate than mural trophectoderm, cells that are not in contact
with the inner cell mass. After implantation, polar trophectoderm
cells proliferate in response to FGF4 and Nodal signaling from the
inner cell mass and give rise to stem cells that later produce the
rest of the trophoblast lineage, whereas mural trophectoderm cells
terminally differentiate into primary TGCs (Copp, 1979; Rossant
and Cross, 2001; Tanaka et al., 1998). Decidua formation is
stimulated by the attachment and invasion of these primary TGCs
into the uterine wall, resulting in initial proliferation and subse-
quent differentiation and hypertrophy of the uterine stromal cells
(Ramathal et al., 2010). The differentiation of decidual cells is
regulated by factors produced by TGCs (Austin et al., 2003; Bany
and Cross, 2006; Herington and Bany, 2007). By mid-gestation,
trophoblast cells stimulate the release of growth and immuno-
regulatory factors from the decidua that are necessary for growth
of the fetus, and promote formation of maternal blood vessels that
deliver blood to the placenta (Blois et al., 2011; Cross et al., 2002).
Morphogenesis of the polar trophectoderm after implantation
gives rise to the ectoplacental cone and extraembryonic ectoderm
(later called the chorion). The cells in ectoplacental cone give rise
to the junctional zone in the mature placenta which is composed
of spongiotrophoblast cells, glycogen cells, and the different
subtypes of TGCs that line maternal blood spaces (Simmons
et al., 2007) and produce several pregnancy related hormones
(Knox et al., 2011; Rawn and Cross, 2008; Tunster et al., 2010).
Glycogen trophoblast cells accumulate vast amounts of glycogen
and migrate into the maternal uterine wall after E12.5 (Adamson
et al., 2002; Gasperowicz et al., 2013b; Mould et al., 2012). They
are hypothesized to function as an energy reserve for fetal growth
and/or the mother to fulﬁll her high-energy requirement during
last phase of pregnancy (Coan et al., 2006; Cross and Mickelson,
2006; Tunster et al., 2010).
The labyrinth is a highly branched structure formed by tropho-
blast cells from the chorion and the allantois, and is specialized for
nutrient and gas supply to the fetus (Simmons et al., 2008a;
Watson and Cross, 2005). Around E8.5, the mesoderm-derived
allantois attaches to the chorion and forms mesenchymal cells and
fetal blood vessels of the labyrinth and umbilical cord (Cross et al.,
2006). The chorion is a ﬂat multilayered structure that undergoes
branching morphogenesis after chorioallantoic attachment
(Simmons et al., 2008a). Chorion trophoblast cells differentiate
to form two types of syncytiotrophoblast cells (layers I and II)
through cell–cell fusion. These cells surround the fetal blood
capillaries forming the major barrier for the nutrient and gas
exchange. Large, mononuclear TGCs line the maternal blood
sinusoids in the labyrinth (Simmons et al., 2007; Watson and
Cross, 2005).
Multiple TGC subtypes line the maternal vasculature in the
mouse placenta
The deﬁning feature of the hemochorial placenta is that
trophoblast cells and not endothelial cells line the maternal
vasculature within the placenta, starting at the level of spiral
arteries for incoming blood and up to the point when nutrient-
and oxygen-depleted blood leaves the placenta to enter into the
uterine veins. In mice, all of the cells lining the maternal blood
space are different subtypes of TGCs. These subtypes have been
classiﬁed based on their location but also developmental origin
and function (Fig. 2), including their differential expression of
several hormones related to Prolactin (Gasperowicz et al., 2013b;
Simmons et al., 2007). Proceeding from upstream to downstream
within the maternal blood space, the ﬁve TGC subtypes are:
(1) spiral artery TGCs (SpA-TGCs) that emerge from the ectopla-
cental cone and invade into the spiral arteries displacing the
Fig. 1. Comparative anatomy of fetal and maternal circulation in the mouse (A) and
human (B) placenta.
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maternal endothelial cells, (2) canal TGCs (C-TGC) that form large
pipe-like structures delivering maternal blood to the bottom of the
labyrinth, (3) sinusoidal TGCs (S-TCG) that sit within the small,
tortuous spaces of the labyrinth, (4) channel TGCs (Ch-TGC) that
line the small channels collecting deoxygenated blood out of
labyrinth, and (5) parietal TGCs (P-TGC) that surround large lakes
(lacunae) of blood leading into the uterine veins. Early in gestation,
the Plf (Prl2c2) gene is expressed in all of the subtypes of TGC
except S-TGC (Simmons et al., 2007). However, in later stages of
gestation, expression of Plf is restricted to SpA-TGC, C-TCG and
P-TGC (Simmons et al., 2007). Pl1 (Prl3d1) expression occurs early
in gestation in P-TGCs, but Pl2 (Prl3b1) appears around E9.5 and has
extensive expression in P-TGCs, spongiotrophoblast, C-TGCs and
S-TGCs (Simmons et al., 2007, 2008b). Cathepsin Q (Ctsq) is a marker
of S- and Ch-TGCs (Gasperowicz et al., 2013b). While the various TGC
subtypes express different genes, all subtypes share the common
feature of a large, polyploid nucleus with large cytoplasm and
extensive golgi and endoplasmic reticulum (Bevilacqua and
Abrahamsohn, 1988; Zybina and Zybina, 1996). They undergo several
rounds of DNA replication without intervening mitosis and cell
division (endoreduplication) resulting in polyploid nuclei with DNA
content up to 1000C (Zybina and Zybina, 1996). The function of
polyploidy is unknown though it has been hypothesized that it is
related to the extensive protein synthesis and secretory function of
TGCs, or the ability to produce rapid tissue growth in less time and
with less energy since these cells have a short life span (Fox and
Duronio, 2013; Hu and Cross, 2010).
Regulation of TGC development
In addition to different gene expression patterns, different sub-
types of TGCs have different cell lineage origins (Fig. 3). Some of the
P-TGCs arise from primary differentiation of mural trophectoderm
and the rest result from secondary differentiation of polar trophec-
toderm derivatives (Gasperowicz et al., 2013b; Simmons et al., 2007).
Lineage-tracing studies using transgenic mice show that TGC sub-
types have alternative developmental origins (Simmons et al., 2007)
and there are stable junctional zone progenitors regulated by Blimp1/
Prdm1 (Mould et al., 2012). All SpA-TGCs but no S-TGCs arise from
Tpbpa-positive cells. By contrast, C-TGCs, Ch-TGCs and P-TGCs have
mixed origins. S-TGCs are presumably derived from cells lining
maternal sinusoids in the upper chorion layer as the labyrinth begins
to develop (Simmons et al., 2008a).
Several genes have been identiﬁed that regulate TGC develop-
ment and, in general, they either suppress or promote differentiation
(Table 1). However, we still have a primitive understanding of how
they function in molecular pathways with a few exceptions. Terminal
differentiation of TGC is considered a ‘default pathway’ as removal of
growth factors that are essential for self-renewal of trophoblast stem
cells (FGF4 and Nodal) leads to TGC fate (Erlebacher et al., 2004;
Guzman-Ayala et al., 2004; Hughes et al., 2004; Natale et al., 2009;
Tanaka et al., 1998). The Mash2 and Hand1 basic helix-loop-helix
transcription factors are expressed in partially overlapping patterns
and coordinate to suppress or promote TGC fate, respectively
(Guillemot et al., 1994; Hughes et al., 2004; Nakayama et al., 1997;
Riley et al., 1998; Scott et al., 2000). Hand1 is critical for differentia-
tion of all TGC subtypes (Simmons et al., 2007) but, to date, there
have been only a few insights into regulators that specify the various
TGC subtypes. Retinoic acid, a derivative of retinol (vitamin A), has
been reported to promote TGC differentiation over spongiotropho-
blast in culture (Yan et al., 2001), though it induces expression of Plf
and Pl1 and suppresses Pl2 and Ctsq, suggesting that it preferentially
induces P-TGCs differentiation but suppresses formation of S-TGCs,
Ch-TGCs and C-TGCs (Simmons et al., 2007). Gata2 restricts expres-
sion of the Prlpa (Prl4a1) hormone gene to P-TGCs (Ma and Linzer,
2000), and Gata3 represses Gata2 gene expression in undifferentiated
trophoblast cells (Ray et al., 2009).
Different lines of evidence suggest that cell–cell communication
inﬂuences P-TGC differentiation. Gap junctions are composed of
connexin proteins, several of which are expressed in the placenta.
Cx31 is expressed in spongiotrophoblast and Cx31-deﬁcient tro-
phoblast stem cells have a reduced ability to express genes that are
characteristic of P-TGCs (Kibschull et al., 2004; Koch et al., 2012)
suggesting that communication between trophoblast progenitor
cells promotes P-TGC differentiation. Consistent with this we have
found that culturing mouse trophoblast stem cells in suspension
produces 3-dimensional spheres containing cells with a P-TGC
phenotype but low or undetectable expression of genes character-
istic of other TGC subtypes (our unpublished observations).
Endothelial vs. vasculogenic mimicry in establishing the
maternal vasculature
Because trophoblast cells assume the location and function of
endothelial cells within the maternal vascular spaces in the
placenta, some authors have described this as “vasculogenic
Fig. 3. Origin of different TGC subtypes in mice. EpC – Ectoplacental cone; ExE –
Extraembryonic ectoderm; ICM – Inner cell mass; and TE – Trophectoderm.
Fig. 2. Detailed structure of the maternal vascular space in the mouse placenta
showing location of different subtypes of TGCs. Arrows indicate the direction of
blood ﬂow. C – maternal canal; C-TGCs – canal trophoblast giant cells; Ch – venous
channels; Ch-TGCs – channel trophoblast giant cells; JZ – junctional zone; P –
parietal venous spaces; P-TGCs – parietal trophoblast giant cells; S – sinusoidal
spaces; S-TGCs – sinusoidal trophoblast giant cells; Sp – spiral artery; and SpA-TGC
– spiral artery-associated trophoblast giant cells.
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mimicry”. However, as described below, trophoblast cells line the
vasculature through two different processes which we distinguish
here: “vascular invasion and endothelial mimicry” describes tro-
phoblast cells that invade into and displace the endothelial cells
from preexisting arteries, taking on the functions of endothelial
cells in the process; “vasculogenic mimicry” describes the phe-
nomenon of trophoblast cells undergoing morphogenesis to create
vascular tubes de novo.
Table 1
Regulators of TGC development.
Gene Gene product Mutant phenotype Reference
Negative regulators of TGC formation
Csf2 Colony stimulating factor 2 (granulocyte-
macrophage)
Mutants have expanded junctional zone
with increased number of glycogen and
TGCs
Sferruzzi-Perri et al. (2009)
Dnmt3L DNA methyltranferase 3-like protein Mutants die at E10.5 with reduced
labyrinth and spongiotrophoblast, TGC
number increased
Arima et al. (2006)
Erf Ets domain transcription factor Mutants die at E10.5, expanded TGC layer
and failure in chorioallantoic attachment.
Papadaki et al. (2007)
Err2 Orphan nuclear receptor Mutants die by E9.5 with chorion absent
and TGC number increased
Luo et al. (1997) and Tremblay et al.
(2001)
Fbw7 F-box protein component of an SCF-type
ubiquitin ligase
Mutant die by E10.5 with TGC number
increased.
Tetzlaff et al. (2004)
FGF4 Fibroblast growth factor Premature TGC formation, mutants die
shortly after implantation
Feldman et al. (1995 and Tanaka et al.
(1998)
Fgfr2 Fibroblast growth factor receptor 2 Mutants die shortly after implantation and
premature TGC formation.
Arman et al. (1998)
Foxd3 Forkhead transcription factor Mutants die at E6.5, TGC number increased. Tompers et al. (2005)
Hop/NECC1 Homeodomain transcription factor Reduced spongiotrophoblast but TGC
number increased
Asanoma et al. (2007)
Mash2/Ascl2 Basic helix-loop-helix transcription factor Mutants die by E10.5, TGC number
increased, spongiotrophoblast, glycogen
trophoblast and labyrinth decreased
Guillemot et al. (1994, Oh-McGinnis et al.
(2011), Scott et al. (2000), Tanaka et al.
(1997)
Nodal Transforming growth factor β superfamily
member
Mutant die at E9.5, TGC number increased. Guzman-Ayala et al. (2004), Ma et al.
(2001)
p53 Tumor suppressor protein, transcription
factor
Mutants die postnatally,
spongiotrophoblast reduced but TGC
number increased
Komatsu et al. (2007), Soloveva and
Linzer (2004)
Socs3 Suppressor of cytokine signaling protein Mutants die at E13.5, with reduced
labyrinth and spongiotrophoblast, TGC
number increased.
Boyle and Robb (2008), Takahashi et al.
(2003)
Positive regulators of TGC formation
Blimp1/ PR domain zinc ﬁnger protein 1 Mutants die at E10.5, disrupted SpATGC, Mould et al. (2012)
Prdm1 Compromised SpT and collapsed labyrinth
layer
Cited2 CBP/p300-interacting trans activator Mutants die at E14.5 with reduced TGC,
spongiotrophoblast and glycogen cells
Withington et al. (2006)
Crim1 Cysteine-rich motor neuron 1 protein Mutants have increased number of
glycogen cells and reduced S-TGCs
Pennisi et al. (2012)
Cx31 Gap junction protein Reduced P-TGC differentiation Kibschull et al. (2004), Koch et al. (2012),
Plum et al. (2001)
EpCAM Epithelial cell adhesion molecule Mutants die at E12.5, vascular defects in
labyrinth and P-TGCs number reduced
Nagao et al. (2009)
Gata2/3 Zinc transcription factors Gata2/ die by E10 and Gata3 / die by
E11.5, TGCs with reduced hormone
synthesis
Ma and Linzer (2000), Ma et al. (1997),
Ray et al. (2009)
Hand 1 Basic helix-loop-helix transcription factor Mutants die by E8.5, TGC number and
nuclear size reduced
Hu et al. (2013), Riley et al. (1998), Scott
et al. (2000)
Jak1 Tyrosine kinase Mutants die perinatally, TGC number
reduced, spongiotrophoblast and labyrinth
disorganized
Takahashi et al. (2008
LIFR Leukemia inhibitory factor receptor Mutants die perinatally, TGC number
reduced, spongiotrophoblast and labyrinth
disorganized
Takahashi et al. (2003), Ware et al. (1995)
NCOA1/3 Nuclear receptor coactivator1/3 Double mutants die at E13.5, labyrinth
expanded with irregular S-TGCs
Chen et al. (2010)
Notch2 Neurogenic locus notch homolog protein 2 Mutants die at E10.5, disorganized
labyrinth and reduced number of TGCs
Hamada et al. (1999), Hunkapiller et al.
(2011)
RAP250 LXXLL-containing coactivator for nuclear
receptors
Mutant die at E13.5, collapsed venous
blood spaces and reduced
spongiotrophoblast
Antonson et al. (2003)
RXR Retinoid X receptor RXRa//RXRb/ die by E10.5 with
labyrinth and junctional zone defects;
RXRa/ die at E16.5
Sapin et al. (1997), Wendling et al. (1999)
Tle3 Transducin-like enhancer protein Mutants die by E14.5, have smaller and
reduced number of P- and Ch-TGCs
Gasperowicz et al. (2013b)
A. Rai, J.C. Cross / Developmental Biology 387 (2014) 131–141134
Vascular invasion and endothelial mimicry
After implantation, the endometrium undergoes changes cri-
tical for formation of new blood vessels at the implantation site as
well as decidualization of the uterine stroma (Ramathal et al.,
2010). The uterine arterial blood supply transverses the myome-
trium and branches into multiple spiral arteries in the decidua that
deliver blood to placenta (Adamson et al., 2002). Trophoblast
invasion begins around E8.5 in mouse and within ﬁrst 12 weeks
in human gestation (Rossant and Cross, 2001): SpA-TGC (mice)
and extravillous cytotrophoblast cells (humans) invade into the
lumen and replace the endothelial lining of the arteries and are
the transition to the hemochorial blood space (Cross et al., 2002;
Harris, 2010) (Fig. 4). In addition to endothelial cell replacement by
trophoblast cells, spiral arteries in normal pregnancies are extre-
mely dilated and lack smooth muscle, a phenomenon called
arterial remodeling. Historically it has been assumed that spiral
artery remodeling is due to trophoblast cell invasion based on the
coincidental ﬁndings of extravillous cytotrophoblast cells in and
around remodeled spiral arteries from normal pregnancies
(Ashton et al., 2005; Whitley and Cartwright, 2009). However,
evidence from uterine natural killer cell (uNK) deﬁcient mice has
suggested that these cells also have a role in spiral artery
remodeling (Croy et al., 2000; Greenwood et al., 2000). This has
been supported by ﬁndings of uNK cells around spiral arteries in
human placenta in vivo as well as by in vitro studies (Hazan et al.,
2010; Robson et al., 2012). As a direct test of the role of trophoblast
cell invasion in spiral artery remodeling, we performed cell
ablation of SpA-TGCs in mice using a transgene-driven cytotoxin.
This results in failure of the spiral arteries to dilate indicating that
SpA-TGCs are indeed required to at least initiate, if not
also complete, the process of spiral artery remodeling (Hu and
Cross, 2011). Emerging evidence suggests cooperation between
SpA-TGCs and uNK cells in regulation of spiral artery remodeling
(Chakraborty et al., 2011).
There are a few plausible mechanisms that may underlie loss
and replacement of endothelial and smooth muscle cells that line
the spiral arteries, and dilation of the arteries. One theory suggests
that spiral artery remodeling is based on degradation of the
extracellular matrix underlying the endothelial and/or smooth
muscle cells leading to apoptosis or altered function. Several
in vivo and in vitro studies in mice have shown up-regulation of
matrix metalloproteinases (MMP) 3, 9 and 14 in trophoblast cells
that are differentiating into TGCs (Armant and Kameda, 1994; Lei
et al., 2007; Whiteside et al., 2001). Similar studies in human
placenta demonstrate loss of extracellular matrix and appearance
of extracellular ﬁbroids coinciding with arrival of extravillous
trophoblast cells in the uterus (Brosens et al., 1967; Pijnenborg
et al., 1983). Extracellular matrix degradation may also be driven
by uNK cells, as they produce several proteases (Harris, 2010).
Trophoblast cells might also induce cell death by cell–cell contact
or secretion of cytokines and growth factors associated with
apoptosis (Whitley and Cartwright, 2009). The rapid removal of
apoptotic tissue poses a limitation in being able to detect the
extent of this process in spiral artery remodeling.
While there is evidence to support extracellular matrix degra-
dation and apoptosis mechanisms, we propose here a third
possibility based on intercellular communication between tropho-
blast cells and the maternal endothelial cells they connect with.
SpA-TGCs and P-TGCs make intimate connections with arterial and
venous endothelial cells, respectively, and while little is known
about what types of junctions exist, maternal blood does not leak
out suggesting close coupling and the two cell types appear to
function as one unit. We suspect that another type of connection
may allow signals from SpA-TGCs to inﬂuence the behavior of
endothelial cells a considerable distance upstream, to promote
spiral artery remodeling. Arteries act as a functional unit by
coordinating the relaxation, contraction and remodeling through
gap junctions between endothelial cells, composed of connexin
(Cx) proteins 37, 40, 43 and 45 (Tran and Welsh, 2009; Welsh and
Taylor, 2012). If SpA-TGCs are functionally linked to endothelial
cells, one would suspect that they would express one or more Cx
proteins that can couple to gap junctions on endothelial cells.
However, while there are several Cx gene expression studies in
placenta that have been published (Kibschull and Winterhager,
2006), they did not focus on these speciﬁc cells. Expression of
several Cx mRNAs, including Cx45, is detected in microarrays from
cultured mouse trophoblast stem cells (http://www.ncbi.nlm.nih.
gov/geo/). Cx45 mouse mutants die around mid-gestation with
vascular defects including in the placenta (Kruger et al., 2000) and
there is a profound lack of maternal blood in the placenta, which
ﬁts with a potential defect in spiral arteries.
Vasculogenic mimicry
Following remodeling, maternal blood enters the mouse pla-
centa through several spiral arteries that, instead of branching into
smaller and smaller arterioles as in other vascular beds, converge
to form a few straight and large diameter structures called canals
that carry the oxygenated blood to the base of the labyrinth,
leading into the tiny sinusoid spaces (Adamson et al., 2002). After
exchange of gases and nutrients between the maternal and
fetal circulation, deoxygenated blood then moves out through
the maze of the labyrinth, converging into channels that traverse
Fig. 4. Vascular invasion and endothelial mimicry by trophoblast cells in spiral
arteries. Spiral artery remodeling occurs either by cell apoptosis or ECM degrada-
tion induced by intravascular trophoblast cells. Some of the potential signaling
molecules are also secreted by uterine natural killer (uNK) cells in decidua. VSMCs
– vascular smooth muscle cells; uNK – uterine natural killer, MMPs – matrix
metalloproteinases, and TIMP – tissue inhibitor of metalloproteinases.
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the junctional zone leading into venous blood spaces lined by
P-TGCs (Adamson et al., 2002). On the venous side, P-TGCs are in
direct contact with endothelial cells within the decidua. Unlike
SpA-TGCs, P-TGC minimally invade the uterus though little is
known about how the connections are made and what prevents
invasion into veins. While it is clear that SpA-TGCs take over pre-
existing arteries, the canals, sinusoids, channels, and lacunae
around P-TGCs are all different in that they form de novo. For this
reason, we recommend that the term “vasculogenic mimicry” be
limited to describe these processes as opposed to what SpA-TGCs
do as being invasion and endothelial mimicry. The best evidence
that trophoblast cells have the intrinsic ability to form vascular
spaces comes from transplantation experiments when trophoblast
cells are injected into nude mice. In these ‘tumors’, large sinus-like
spaces appear in which host blood is in direct contact with TGCs
that form in situ and, as in the placenta, the blood does not clot
unlike a hemorrhage (Hemberger et al., 2003b; Kibschull et al.,
2004; Kibschull and Winterhager, 2006).
Similarities between TGCs and endothelial cells
Regulators of angiogenesis
During early stages of vascular development by endothelial
cells, unpolarized endothelial precursor cells initially form a
capillary plexus with cord-like structures that do not have a lumen
(Hirashima, 2009; Hogan and Kolodziej, 2002). The plexus is
eventually remodeled to form a lumen (Hogan and Kolodziej,
2002). Perivascular cells such as pericytes and smooth muscle cells
are later recruited for maturation of early vascular circuit (Herbert
and Stainier, 2011; Hirashima, 2009) (Fig. 5). Apical-basal polar-
ization and cell movement is the standard mechanism for lumen
formation by endothelial cells during both vasculogenesis and
angiogenesis (Fig. 5). Adherent cells tether to form a slit that
expands to form a lumen, regulated by signaling molecules that
trigger cytoskeletal changes and cell motility (Hogan and
Kolodziej, 2002). Though there is no direct evidence of this
phenomenon occurring in TGCs within the placenta, cytoskeletal
transition of TGCs does occur in vitro as the cells adapt a more
endothelial-like phenotype (Parast et al., 2001). TGCs have been
reported to express the VEGF receptor (VEGFR2) (Abbott and
Buckalew, 2000), and VEGF has been shown to promote widening
of the lumen by prompting cytoskeletal changes in endothelial
cells (Lammert and Axnick, 2012). Though it cannot be ruled out,
we have not observed signiﬁcant apoptosis in trophoblast cells
during formation of blood spaces in the junctional zone and
labyrinth (our unpublished observations). Therefore, it is reason-
able to hypothesize that cell polarization, motility and cytoskeletal
transition drive morphogenesis of the maternal vascular spaces
within the placenta.
Following vasculogenesis, endothelial cells acquire an arterial
or venous fate in response to transcription factors such as Hey1
and Hey2 (Fischer et al., 2004) which are downstream effectors of
Notch signaling and promote arterial differentiation (Zhong et al.,
2001). Other components of Notch signaling pathway such as
Notch1, Notch4, Jagged1 and Dll4 are also involved in develop-
ment of the embryonic vasculature (Hirashima, 2009). Hence,
Notch signaling is a key factor for arterial endothelial differentia-
tion. By contrast, Coup-TFII promotes venous differentiation by
inhibiting Notch signaling (You et al., 2005). Genes encoding
various Notch signaling components such as Jagged1/2, Dll1/4,
Hes1, Tle1/2/3 and Notch1/2/3/4 are expressed in trophoblast cells
in the human and mouse placenta (Cobellis et al., 2007;
Gasperowicz et al., 2013a, 2013b; Hamada et al., 1999; Herr
et al., 2011; Hunkapiller et al., 2011). Notch2 and Tle3 mouse
mutants have defects in the maternal vascular circuit within the
placenta (Gasperowicz et al., 2013b; Hunkapiller et al., 2011).
Interestingly, Notch2 primarily regulates the development and
function of SpA-TGCs and C-TGCs (Gasperowicz et al., 2013b;
Hunkapiller et al., 2011). Both these TGC subtypes line the arterial
side of maternal vascular circuit supporting the hypothesis that
Notch signaling in trophoblast cells may determine an arterial-like
fate of these cells. Coup-TFII mutant embryos die due to vascular
defects but they also have a severe phenotype in the placenta as
well. Though the placenta phenotype has not been studied in
detail, the results suggest that Coup-TFII might be working in
opposition to Notch signaling.
Other key regulators of vascular development are the Vascular
Endothelial Growth Factors (VEGF) (Yancopoulos et al., 2000).
Angiogenic blood vessels have elevated expression of VEGFs.
VEGF-A binds to two receptor tyrosine kinases, VEGF receptor
1 and 2, also called Flt1 and Flk1, respectively. Both VEGFR1 and
VEGFR2 are expressed in the mouse placenta (Hirashima et al.,
2003). VEGFR1 is expressed throughout the placenta in differen-
tiated TGCs whereas VEGFR2 expression has not been detected in
the spiral artery region (Hirashima et al., 2003). Since the two
receptors have antagonistic effects based on their knockout
phenotypes (Yancopoulos et al., 2000), they may play a role in
establishing differential fate of TGCs during development of the
maternal vascular spaces. Placental growth factor (PlGF), another
angiogenic growth factor, is also secreted by TGCs in the placenta
(Achen et al., 1997). The presence of VEGF receptors as well as
secretion of VEGF and PlGF by TGCs suggests autocrine or para-
crine actions. Though VEGF is critical for vascular development
and angiogenic sprouting, alone it forms immature vessels. For
maturation and stabilization of blood vessels, angiopoietins and
ephrin-B2 are necessary (Herbert and Stainier, 2011; Hogan and
Kolodziej, 2002; Yancopoulos et al., 2000). These factors are also
expressed by trophoblast cells in the human placenta (Goldman-
Wohl et al., 2000, 2004; Red-Horse et al., 2005; Zhou et al., 2003a).
Endothelial cell functions
In addition to angiogenic factors, mouse TGCs and human
extravillous cytotrophoblast cells exhibit many other features of
endothelial cells including expression of several endothelial-type cell
adhesion molecules and anti-coagulation properties (Table 2). Blood
vessels lined by endothelial cells proactively suppress coagulation to
avoid thrombogenesis. Activation and repression of coagulation is a
crucial gene-expression switch in order to maintain tissue home-
ostasis (Lanir et al., 2003). The major anti-coagulant factors produced
Fig. 5. Sequence of events during vasculogenesis. Angioblasts or other precursors
forms small dense masses that later arrange into a tubular plexus that forms a
blood vessel. After rearrangement of endothelial cells, lumen formation occurs
either by apical–basal movement of cells or apoptosis. Once the tube is formed, it
matures and stabilizes by pericyte and smooth muscle association.
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by trophoblast cells are thrombomodulin, tissue factor pathway
inhibitor (TFPI), Annexin V, endothelial protein C receptor (EPCR)
(Lanir et al., 2003; Sood et al., 2006; Wang et al., 1999). Unlike
endothelial cells, trophoblast cells also paradoxically express pro-
coagulant factors like tissue factor (TF) (Lanir et al., 2003). Therefore,
there must be an intricate interplay in gene expression to maintain
an endothelial-like anticoagulant state.
Endothelial cells are coupled together within blood vessels by
tight junctions and gap junctions (Sohl and Willecke, 2004). To
establish the maternal vascular circuit within the placenta, TGCs
must tightly interact with endothelial cells on both arterial
and venous sides and with each other within the placenta itself.
Electron microscopy shows that P-TGCs lining the venous spaces
form tight junctions among themselves similar to tight junctions
between endothelial cells lining the maternal veins (Fig. 6). P-TGCs
also interact with endothelial cells by establishing strong
intercellular junctions. While we do not yet know the molecular
nature of these junctions and what regulates their formation,
it is clear that these endothelial-trophoblast connections
are critical for formation of the maternal vascular circuit in the
placenta.
Similarity between trophoblast cells and tumor cells
The ability of trophoblast cells to invade pre-existing blood
vessels and also develop vessel-like structures is similar to the
behavior of some cancers. Several extracellular matrix degrading
components necessary for migration and invasion are shared
between tumor cells and TGCs (Table 2). The de novo formation
of ﬂuid conducting channels without participation of endothelial
cells (vasculogenic mimicry) has been described in various aggres-
sive tumors such as uveal melanoma, cutaneous melanoma,
choriocarcinoma and gliobastoma (Folberg et al., 2000; Hendrix
et al., 2003). The vascular channels generated by tumor cells
connect with pre-existing blood vessels that infuse blood into
the tumor. Like TGCs, tumor cells lining the vasculature have gene
expression patterns similar to endothelial cells and express
endothelial-like anticoagulants (Folberg et al., 2000; Paulis et al.,
2010). Various growth factors necessary for vessel generation such
as VEGFs, FGFs, PlGF and other cytokines are expressed in both
tumor cells and TGCs (Achen et al., 1997). Unlike these aggressive
tumor types, trophoblast cells in the placenta are normally well
regulated though disruption in regulation may underlie the
transformation of trophoblast to choriocarcinoma, with unregu-
lated invasion and vasculogenic mimicry (Ferretti et al., 2007; Shih
Ie, 2011; Soundararajan and Rao, 2004).
Conclusions and future directions
The development and function of TGCs that line the maternal
blood spaces within the placenta is a unique and very interesting
phenomenon. The apparent overlap in regulators and functions of
TGCs with endothelial and tumor cells makes it a great model to
understand the cellular and molecular events that regulate vas-
cular development. Though our understanding has increased in
recent years, there are still several critical gaps. One of the most
striking ﬁndings in studies of the mouse placenta is the variety of
TGC subtypes that line the maternal vasculature in the placenta,
but this complexity has not been addressed in the human
placenta. Mutant mouse models have revealed that defects in
the maternal vasculature or function of TGCs leads to birth defects
or fetal death, similar to preeclampsia or miscarriage in humans.
We suspect that, as in the mouse, there is more than one type of
cytotrophoblast cell lining the maternal vasculature in the human
placenta but tools need to be identiﬁed to more closely analyze the
human placenta. The mechanisms regulating vascular invasion and
endothelial mimicry as well as vasculogenic mimicry are just
beginning to be investigated and there are several basic questions
Table 2
Expression of vascular molecules in endothelial, trophoblast and tumor cells. Question mark (?) indicates that expression pattern is unknown.
Name Endothelial
cells
Trophoblast
cells
Tumor
cells
Reference
Angiogenesis
VEGF-A ✓ ✓ ✓ Liu et al. (1995), Rak et al. (1995)
VEGF-B ✓ ? ✓ Olofsson et al. (1996), Salven et al. (1998)
VEGF-C ✓ ? ✓ Joukov et al. (1996), Salven et al. (1998)
VEGF-D ✓ ? ✓ Makinen et al. (2001), Stacker et al. (2001)
PlGF ✓ ✓ ✓ Achen et al. (1997), Carmeliet et al. (2001), Hauser and Weich (1993)
VEGFR2 ✓ ✓ ✓ Abbott and Buckalew (2000), Vartanian et al. (2011)
Thrombosis
Adrenomedullin ✓ ✓ ✓ Caron and Smithies (2001), Li et al. (2013), Sugo et al. (1994), Zudaire et al. (2003)
Thrombomodulin ✓ ✓ ✓ Hanly et al. (2005), Hemberger et al. (2003a), Martin et al. (2013), Weiler-Guettler
et al. (1996)
Tissue factor ? ✓ ✓ Contrino et al. (1996), Hemberger et al. (2003a), Lanir et al. (2003)
Annexins ✓ ✓ ✓ Flood and Hajjar (2011), Sood et al. (2006), Wang et al. (1999)
Tissue factor pathway inhibitor
(TFPI)
✓ ✓ ✓ Bajaj et al. (2001), Hemberger et al. (2003a)
Endothelial protein C receptor
(EPCR)
✓ ✓ ? Gu et al. (2002), Sood et al. (2006)
Cell adhesion
Tight junctions ✓ ✓ ✓ Runkle and Mu (2013)
Gap junctions ✓ ✓ ✓ Cronier et al. (2009, Kibschull and Winterhager (2006), Sohl and Willecke (2004)
E-Cadherin ✓ ✓ ✓ Dejana, (2004), Nagao et al. (2009), Paredes et al. (2012)
P-Cadherin - ✓ ✓ Madeja et al. (2011), Paredes et al. (2012)
VE-Cadherin ✓ ✓ ✓ Zhou et al. (1997)
E-Selectin ✓ ✓ ✓ Milstone et al. (2000), Zhou et al. (2003b)
PECAM1 ✓ ✓ ✓ Blankenship and Enders (1997)
ECM modiﬁcation
MMPs ✓ ✓ ✓ Hemberger et al. (2004), Liotta et al. (1982), Rundhaug (2003), Unemori et al. (1992)
Tissue inhibitor of
metalloproteinase
✓ ✓ ✓ De Lorenzo et al. (2000), Hemberger et al. (2004)
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to be answered. While the associations between endothelial cells
and TGCs on the spiral artery and venous side can probably only be
studied in vivo, development of in vitro models would greatly
assist the study of “trophoblast vasculogenesis” which creates the
canal, sinusoid, channels and lacunar spaces. Finally, there are
some studies suggesting that VEGF and its receptors are expressed
by TGCs and yet VEGF control of TGC biology has not been
investigated. Since TGC subtypes are differentially located along
the oxygenated and deoxygenated blood circuit in the placenta,
the expression of VEGFs is likely to be selective. The increasing
availability of in vitro models and Cre recombinase transgenic
mice for conditional gene knockout or mis-expression of genes
means that these questions can ﬁnally be addressed.
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